Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors
- 1 August 1982
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 8 (3) , 285-291
- https://doi.org/10.1007/bf00254052
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Heuristic modeling of drug delivery to malignant brain tumorsJournal of Pharmacokinetics and Biopharmaceutics, 1980
- CEREBROSPINAL-FLUID POLYAMINES IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME AND ANAPLASTIC ASTROCYTOMA1980
- PREDICTIVE VALUE OF CEREBROSPINAL-FLUID POLYAMINES IN MEDULLOBLASTOMA1979
- Current status of intrathecal chemotherapy for human meningeal neoplasms.1977
- Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.1975
- Proliferative kinetics of central nervous system (CNS) leukemiaCancer, 1975
- Factors in Pathogenesis of Central-nervous-system LeukaemiaBMJ, 1972
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.1970
- Effect of Antimetabolites on Kinetic Behavior of Proliferating Cultured L1210 Leukemia Cells2JNCI Journal of the National Cancer Institute, 1967